Are 5'-O-carbamate-2',3'-dideoxythiacytidine new anti-HIV and anti-HBV nucleoside drugs or prodrugs? 2003

Carole Anastasi, and Patrick Vlieghe, and Olivier Hantz, and Olivier Schorr, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq, and Pascal Clayette, and Nathalie Dereuddre-Bosquet, and Dominique Dormont, and Françoise Gondois-Rey, and Ivan Hirsch, and Jean-Louis Kraus
Laboratoire de Chimie Biomoléculaire, INSERM U-382, IBDM, Université Méditerranée, Parc Scientifique de Luminy, 163 avenue de Luminy, case 901, 13288 Marseille Cedex 9, France.

In contrast to 5'-O-carbonate 3TC derivatives (23, 24), which are clearly 3TC prodrugs, the corresponding 3TC carbamates (15-21 and 25), found to be very stable compounds with respect to enzymatic hydrolysis (cellular lysates and culture cell media) and still active on both HIV-1 and HBV infected cells, may not be 3TC prodrugs. The antiviral properties as well as the mechanism of action of 3TC analogues have been studied and evaluated.

UI MeSH Term Description Entries
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Carole Anastasi, and Patrick Vlieghe, and Olivier Hantz, and Olivier Schorr, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq, and Pascal Clayette, and Nathalie Dereuddre-Bosquet, and Dominique Dormont, and Françoise Gondois-Rey, and Ivan Hirsch, and Jean-Louis Kraus
August 2001, Journal of medicinal chemistry,
Carole Anastasi, and Patrick Vlieghe, and Olivier Hantz, and Olivier Schorr, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq, and Pascal Clayette, and Nathalie Dereuddre-Bosquet, and Dominique Dormont, and Françoise Gondois-Rey, and Ivan Hirsch, and Jean-Louis Kraus
July 2011, Chemical biology & drug design,
Carole Anastasi, and Patrick Vlieghe, and Olivier Hantz, and Olivier Schorr, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq, and Pascal Clayette, and Nathalie Dereuddre-Bosquet, and Dominique Dormont, and Françoise Gondois-Rey, and Ivan Hirsch, and Jean-Louis Kraus
March 2001, Journal of medicinal chemistry,
Carole Anastasi, and Patrick Vlieghe, and Olivier Hantz, and Olivier Schorr, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq, and Pascal Clayette, and Nathalie Dereuddre-Bosquet, and Dominique Dormont, and Françoise Gondois-Rey, and Ivan Hirsch, and Jean-Louis Kraus
January 2003, Nucleosides, nucleotides & nucleic acids,
Carole Anastasi, and Patrick Vlieghe, and Olivier Hantz, and Olivier Schorr, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq, and Pascal Clayette, and Nathalie Dereuddre-Bosquet, and Dominique Dormont, and Françoise Gondois-Rey, and Ivan Hirsch, and Jean-Louis Kraus
December 2012, Chemical biology & drug design,
Carole Anastasi, and Patrick Vlieghe, and Olivier Hantz, and Olivier Schorr, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq, and Pascal Clayette, and Nathalie Dereuddre-Bosquet, and Dominique Dormont, and Françoise Gondois-Rey, and Ivan Hirsch, and Jean-Louis Kraus
June 2020, Journal of medicinal chemistry,
Carole Anastasi, and Patrick Vlieghe, and Olivier Hantz, and Olivier Schorr, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq, and Pascal Clayette, and Nathalie Dereuddre-Bosquet, and Dominique Dormont, and Françoise Gondois-Rey, and Ivan Hirsch, and Jean-Louis Kraus
July 2000, Nucleosides, nucleotides & nucleic acids,
Carole Anastasi, and Patrick Vlieghe, and Olivier Hantz, and Olivier Schorr, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq, and Pascal Clayette, and Nathalie Dereuddre-Bosquet, and Dominique Dormont, and Françoise Gondois-Rey, and Ivan Hirsch, and Jean-Louis Kraus
September 1990, Journal of medicinal chemistry,
Carole Anastasi, and Patrick Vlieghe, and Olivier Hantz, and Olivier Schorr, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq, and Pascal Clayette, and Nathalie Dereuddre-Bosquet, and Dominique Dormont, and Françoise Gondois-Rey, and Ivan Hirsch, and Jean-Louis Kraus
May 1992, Journal of medicinal chemistry,
Carole Anastasi, and Patrick Vlieghe, and Olivier Hantz, and Olivier Schorr, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq, and Pascal Clayette, and Nathalie Dereuddre-Bosquet, and Dominique Dormont, and Françoise Gondois-Rey, and Ivan Hirsch, and Jean-Louis Kraus
September 2003, Antiviral chemistry & chemotherapy,
Copied contents to your clipboard!